Yu Li

机构：Guangdong Pharmaceutical University · ORCID：0000-0002-3492-6325

发表论文 76 篇 · 总被引 1269 次 · h-index 21

代表论文

• Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy (2023 · Nature Communications · 被引 118)
• Lactiplantibacillus plantarum ATCC8014 Alleviates Postmenopausal Hypercholesterolemia in Mice by Remodeling Intestinal Microbiota to Increase Secondary Bile Acid Excretion (2024 · Journal of Agricultural and Food Chemistry · 被引 17)
• Ligustrazine and liguzinediol protect against doxorubicin‐induced cardiomyocytes injury by inhibiting mitochondrial apoptosis and autophagy (2023 · Clinical and Experimental Pharmacology and Physiology · 被引 16)
• Monocyte-related gene biomarkers for latent and active tuberculosis (2021 · Bioengineered · 被引 16)
• Identification and characterization of variants in PSEN1, PSEN2, and APP genes in Chinese patients with early-onset Alzheimer's disease (2025 · Alzheimer s Research & Therapy · 被引 15)
• Quinolone Resistance Genes and Their Contribution to Resistance in Vibrio cholerae Serogroup O139 (2023 · Antibiotics · 被引 12)